Results 1 - 20 of 1,187 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (1,169)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysisBMJ (Online), 2022-03, Vol.376, p.e068632-e068632 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-068632 ;PMID: 35236664Full text available |
| 2 |
Material Type: Article
|
|
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBlood, 2021-10, Vol.138 (14), p.1278-1281 [Peer Reviewed Journal]2021 American Society of Hematology ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021012769 ;PMID: 34339501Full text available |
| 3 |
Material Type: Article
|
|
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunityCell, 2021-04, Vol.184 (9), p.2372-2383.e9 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.013 ;PMID: 33743213Full text available |
| 4 |
Material Type: Article
|
|
Viral targets for vaccines against COVID-19Nature reviews. Immunology, 2021-02, Vol.21 (2), p.73-82 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00480-0 ;PMID: 33340022Full text available |
| 5 |
Material Type: Article
|
|
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494Digital Resources/Online E-Resources |
| 6 |
Material Type: Article
|
|
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine ImplicationsNew England Journal of Medicine, 2021-05, Vol.384 (19), p.1866-1868 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2100362 ;PMID: 33761203Digital Resources/Online E-Resources |
| 7 |
Material Type: Article
|
|
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantNew England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274Digital Resources/Online E-Resources |
| 8 |
Material Type: Article
|
|
COVID-19 vaccines: where we stand and challenges aheadCell death and differentiation, 2021-02, Vol.28 (2), p.626-639 [Peer Reviewed Journal]The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021. ;The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021 ;ISSN: 1350-9047 ;EISSN: 1476-5403 ;DOI: 10.1038/s41418-020-00720-9 ;PMID: 33479399Full text available |
| 9 |
Material Type: Article
|
|
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationThe Lancet (British edition), 2021-06, Vol.397 (10292), p.2331-2333 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01290-3 ;PMID: 34090624Full text available |
| 10 |
Material Type: Article
|
|
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724Full text available |
| 11 |
Material Type: Article
|
|
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionNature (London), 2021-11, Vol.599 (7883), p.114-119 [Peer Reviewed Journal]2021. The Author(s). ;Copyright Nature Publishing Group Nov 4, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03944-y ;PMID: 34488225Full text available |
| 12 |
Material Type: Article
|
|
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron InfectionNew England Journal of Medicine, 2022-02, Vol.386 (5), p.492-494 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119358 ;PMID: 34965337Digital Resources/Online E-Resources |
| 13 |
Material Type: Article
|
|
Adaptive immunity to SARS-CoV-2 and COVID-19Cell, 2021-02, Vol.184 (4), p.861-880 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.01.007 ;PMID: 33497610Digital Resources/Online E-Resources |
| 14 |
Material Type: Article
|
|
Plasma Neutralization of the SARS-CoV-2 Omicron VariantNew England Journal of Medicine, 2022-02, Vol.386 (6), p.599-601 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119641 ;PMID: 35030645Digital Resources/Online E-Resources |
| 15 |
Material Type: Article
|
|
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent PersonsNew England Journal of Medicine, 2022-02, Vol.386 (7), p.698-700 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119236 ;PMID: 35021005Digital Resources/Online E-Resources |
| 16 |
Material Type: Article
|
|
Antibody Response to COVID-19 Vaccination in Patients Receiving DialysisJournal of the American Society of Nephrology, 2021-10, Vol.32 (10), p.2435-2438 [Peer Reviewed Journal]Copyright © 2021 by the American Society of Nephrology 2021 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2021050611 ;PMID: 34117129Full text available |
| 17 |
Material Type: Article
|
|
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralizationCell host & microbe, 2021-05, Vol.29 (5), p.747-751.e4 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.04.007 ;PMID: 33887205Full text available |
| 18 |
Material Type: Article
|
|
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escapeNature reviews. Immunology, 2021-10, Vol.21 (10), p.626-636 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00592-1 ;PMID: 34373623Full text available |
| 19 |
Material Type: Article
|
|
Myocarditis With COVID-19 mRNA VaccinesCirculation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357Full text available |
| 20 |
Material Type: Article
|
|
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safetyNature reviews. Clinical oncology, 2022-06, Vol.19 (6), p.385-401 [Peer Reviewed Journal]2022. Springer Nature Limited. ;Springer Nature Limited 2022. ;Springer Nature Limited 2022 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-022-00610-8 ;PMID: 35277694Full text available |
Results 1 - 20 of 1,187 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (1,169)
Refine My Results
Creation Date
- Before 2020 (1)
- 2020 To 2020 (74)
- 2021 To 2021 (661)
- 2022 To 2023 (344)
- After 2023 (108)
-
More options
New Records
Subject
- Covid-19 Vaccines - Immunology (1,184)
- Humans (1,112)
- Science & Technology (1,045)
- Life Sciences & Biomedicine (864)
- Covid-19 - Prevention & Control (835)
- Sars-Cov-2 - Immunology (775)
- Covid-19 - Immunology (685)
- Covid-19 (653)
- Severe Acute Respiratory Syndrome Coronavirus 2 (588)
- Vaccines (584)
- Coronaviruses (538)
- Sars-Cov-2 (518)
- Vaccination (509)
- Covid-19 Vaccines (431)
- Female (425)
- Male (368)
- Covid-19 Vaccines - Administration & Dosage (364)
- Immunology (353)
- Spike Glycoprotein, Coronavirus - Immunology (327)
- Middle Aged (309)
-
More options
Databases
- MEDLINE (1,184)
- ProQuest Central (717)
- Open Access: PubMed Central (627)
- DOAJ Directory of Open Access Journals (596)
- Freely Accessible Journals (540)
- ROAD: Directory of Open Access Scholarly Resources (460)
- Coronavirus Research Database (355)
- ProQuest One Psychology (179)
- HighWire Press (Free Journals) (131)
- Nature Free (130)
- Cell Press Archives (Open access) (63)
- Taylor & Francis Open Access (62)
- JSTOR Early Journal Content Free (46)
- SpringerOpen (43)
- PLoS (Open access) (37)
- Wiley Online Library Open Access (36)
- Journals@Ovid Open Access Journal Collection Rolling (34)
- Hyper Article en Ligne (HAL) (Open Access) (14)
- SWEPUB Freely available online (12)
- BMJ Open Access Journals (11)
-
More options
Language
- English (1,185)
- Japanese (231)
- Portuguese (2)
- Chinese (2)
- Spanish (2)
- Norwegian (1)
-
More options
Journal Title
- Frontiers In Immunology (109)
- Human Vaccines & Immunotherapeutics (31)
- Nature (86)
- Nature Communications (37)
- New England Journal Of Medicine (36)
- Plos One (26)
- Scientific Reports (34)
- The Lancet Infectious Diseases (28)
- The New England Journal Of Medicine (65)
- Viruses (42)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||